GALTVSLRCX• 6 Months (Normalized)
GALT vs LRCX (Galectin Therapeutics Inc. vs Lam Research Corporation)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GALT Performance $3.91
+22.96%
Galectin Therapeutics Inc.
Normalized Baseline0.00%
LRCX Performance $298.22
+35.93%
Lam Research Corporation
Normalized Baseline0.00%
Alpha Spread Margin LRCX LEADS
-12.97%
LRCX outperforming by 12.97%
GALTLRCX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GALT LRCX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | GALT Price | GALT Gain (%) | LRCX Price | LRCX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.91 | +22.96% | $298.22 | +35.93% | -12.97% |
| Sep 10, 2026 | $3.90 | +22.64% | $298.01 | +35.83% | -13.19% |
| Sep 09, 2026 | $4.05 | +27.36% | $315.84 | +43.96% | -16.60% |
| Sep 08, 2026 | $4.14 | +30.19% | $320.42 | +46.04% | -15.85% |
| Sep 04, 2026 | $4.61 | +44.97% | $307.65 | +40.22% | +4.75% |
| Sep 03, 2026 | $4.35 | +36.79% | $292.66 | +33.39% | +3.40% |
| Sep 02, 2026 | $4.48 | +40.88% | $288.32 | +31.41% | +9.47% |
| Sep 01, 2026 | $4.17 | +31.13% | $290.20 | +32.27% | -1.14% |
| Aug 31, 2026 | $3.95 | +24.21% | $301.49 | +37.42% | -13.21% |
| Aug 28, 2026 | $4.02 | +26.42% | $301.90 | +37.60% | -11.18% |
| Aug 27, 2026 | $4.14 | +30.19% | $318.58 | +45.21% | -15.02% |
| Aug 26, 2026 | $4.15 | +30.50% | $312.88 | +42.61% | -12.11% |
| Aug 25, 2026 | $3.99 | +25.47% | $314.66 | +43.42% | -17.95% |
| Aug 24, 2026 | $3.88 | +22.01% | $310.17 | +41.37% | -19.36% |
| Aug 21, 2026 | $3.68 | +15.72% | $314.00 | +43.12% | -27.40% |
Page 1 of 9